0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Proteins and Peptides Market Research Report 2026
Published Date: 2026-03-31
|
Report Code: QYRE-Auto-32T9537
Home | Market Reports
Global Oral Proteins and Peptides Market Insights and Forecast to 2028
BUY CHAPTERS

Global Oral Proteins and Peptides Market Research Report 2026

Code: QYRE-Auto-32T9537
Report
2026-03-31
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Proteins and Peptides Market Size

The global Oral Proteins and Peptides market was valued at US$ 2705 million in 2025 and is anticipated to reach US$ 7230 million by 2032, at a CAGR of 15.3% from 2026 to 2032.

Oral Proteins and Peptides Market

Oral Proteins and Peptides Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Oral Proteins and Peptides competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention, treatment and diagnosis. Polypeptide is a compound formed by linking α-amino acids together with a peptide chain, and it is also an intermediate product of proteolysis. N polypeptide chains are entangled in a certain spatial structure to form a protein. The hydrolysis of macromolecular proteins produces polypeptides. Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.
With the breakthrough of delivery technology, oral alternatives to injections have become a new trend, improving patient compliance and driving market growth.
The demand for oral protein and peptide drugs for the treatment of chronic diseases (such as diabetes and inflammatory bowel disease) continues to rise.
Nano-delivery systems and enzyme inhibition encapsulation technologies continue to mature, solving gastrointestinal degradation problems and expanding product development space.
Many biopharmaceutical companies around the world are advancing clinical trials and cooperative development to accelerate the commercialization process.
Despite regulatory challenges and cost pressures, the oral protein/peptide market is still seen as a high-potential blue ocean track.
This report delivers a comprehensive overview of the global Oral Proteins and Peptides market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Oral Proteins and Peptides. The Oral Proteins and Peptides market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Oral Proteins and Peptides market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Oral Proteins and Peptides manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Oral Proteins and Peptides Market Report

Report Metric Details
Report Name Oral Proteins and Peptides Market
Accounted market size in 2025 US$ 2705 million
Forecasted market size in 2032 US$ 7230 million
CAGR 15.3%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Linaclotide
  • Insulin
  • Plecanatide
  • Cyclosporine
  • Octreotide
by Application
  • Gastric & Digestive Disorders
  • Bone Diseases
  • Diabetes
  • Hormonal Disorders
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Oral Proteins and Peptides manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Oral Proteins and Peptides sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Oral Proteins and Peptides Market growing?

Ans: The Oral Proteins and Peptides Market witnessing a CAGR of 15.3% during the forecast period 2026-2032.

What is the Oral Proteins and Peptides Market size in 2032?

Ans: The Oral Proteins and Peptides Market size in 2032 will be US$ 7230 million.

Who are the main players in the Oral Proteins and Peptides Market report?

Ans: The main players in the Oral Proteins and Peptides Market are Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma)

What are the Application segmentation covered in the Oral Proteins and Peptides Market report?

Ans: The Applications covered in the Oral Proteins and Peptides Market report are Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders

What are the Type segmentation covered in the Oral Proteins and Peptides Market report?

Ans: The Types covered in the Oral Proteins and Peptides Market report are Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide

1 Oral Proteins and Peptides Market Overview
1.1 Product Definition
1.2 Oral Proteins and Peptides by Type
1.2.1 Global Oral Proteins and Peptides Market Value by Type: 2025 vs 2032
1.2.2 Linaclotide
1.2.3 Insulin
1.2.4 Plecanatide
1.2.5 Cyclosporine
1.2.6 Octreotide
1.3 Oral Proteins and Peptides by Application
1.3.1 Global Oral Proteins and Peptides Market Value by Application: 2025 vs 2032
1.3.2 Gastric & Digestive Disorders
1.3.3 Bone Diseases
1.3.4 Diabetes
1.3.5 Hormonal Disorders
1.4 Global Oral Proteins and Peptides Market Size Estimates and Forecasts
1.4.1 Global Oral Proteins and Peptides Revenue 2021–2032
1.4.2 Global Oral Proteins and Peptides Sales 2021–2032
1.4.3 Global Oral Proteins and Peptides Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Oral Proteins and Peptides Market Competition by Manufacturers
2.1 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2021–2026)
2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Oral Proteins and Peptides, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Oral Proteins and Peptides, Product Types and Applications
2.7 Global Key Manufacturers of Oral Proteins and Peptides, Date of Entry into the Industry
2.8 Global Oral Proteins and Peptides Market Competitive Situation and Trends
2.8.1 Global Oral Proteins and Peptides Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Oral Proteins and Peptides Players Market Share by Revenue
2.8.3 Global Oral Proteins and Peptides Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Proteins and Peptides Market Scenario by Region
3.1 Global Oral Proteins and Peptides Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Oral Proteins and Peptides Sales by Region: 2021–2032
3.2.1 Global Oral Proteins and Peptides Sales by Region: 2021–2026
3.2.2 Global Oral Proteins and Peptides Sales by Region: 2027–2032
3.3 Global Oral Proteins and Peptides Revenue by Region: 2021–2032
3.3.1 Global Oral Proteins and Peptides Revenue by Region: 2021–2026
3.3.2 Global Oral Proteins and Peptides Revenue by Region: 2027–2032
3.4 North America Oral Proteins and Peptides Market Facts & Figures by Country
3.4.1 North America Oral Proteins and Peptides Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Oral Proteins and Peptides Sales by Country (2021–2032)
3.4.3 North America Oral Proteins and Peptides Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Proteins and Peptides Market Facts & Figures by Country
3.5.1 Europe Oral Proteins and Peptides Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Oral Proteins and Peptides Sales by Country (2021–2032)
3.5.3 Europe Oral Proteins and Peptides Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Proteins and Peptides Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Oral Proteins and Peptides Sales by Region (2021–2032)
3.6.3 Asia Pacific Oral Proteins and Peptides Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Oral Proteins and Peptides Market Facts & Figures by Country
3.7.1 Latin America Oral Proteins and Peptides Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Oral Proteins and Peptides Sales by Country (2021–2032)
3.7.3 Latin America Oral Proteins and Peptides Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Proteins and Peptides Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Oral Proteins and Peptides Sales by Country (2021–2032)
3.8.3 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Proteins and Peptides Sales by Type (2021–2032)
4.1.1 Global Oral Proteins and Peptides Sales by Type (2021–2026)
4.1.2 Global Oral Proteins and Peptides Sales by Type (2027–2032)
4.1.3 Global Oral Proteins and Peptides Sales Market Share by Type (2021–2032)
4.2 Global Oral Proteins and Peptides Revenue by Type (2021–2032)
4.2.1 Global Oral Proteins and Peptides Revenue by Type (2021–2026)
4.2.2 Global Oral Proteins and Peptides Revenue by Type (2027–2032)
4.2.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2021–2032)
4.3 Global Oral Proteins and Peptides Price by Type (2021–2032)
5 Segment by Application
5.1 Global Oral Proteins and Peptides Sales by Application (2021–2032)
5.1.1 Global Oral Proteins and Peptides Sales by Application (2021–2026)
5.1.2 Global Oral Proteins and Peptides Sales by Application (2027–2032)
5.1.3 Global Oral Proteins and Peptides Sales Market Share by Application (2021–2032)
5.2 Global Oral Proteins and Peptides Revenue by Application (2021–2032)
5.2.1 Global Oral Proteins and Peptides Revenue by Application (2021–2026)
5.2.2 Global Oral Proteins and Peptides Revenue by Application (2027–2032)
5.2.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2021–2032)
5.3 Global Oral Proteins and Peptides Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Ironwood & Allergan (AbbVie)
6.1.1 Ironwood & Allergan (AbbVie) Company Information
6.1.2 Ironwood & Allergan (AbbVie) Description and Business Overview
6.1.3 Ironwood & Allergan (AbbVie) Oral Proteins and Peptides Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Ironwood & Allergan (AbbVie) Oral Proteins and Peptides Product Portfolio
6.1.5 Ironwood & Allergan (AbbVie) Recent Developments/Updates
6.2 Novo Nordisk
6.2.1 Novo Nordisk Company Information
6.2.2 Novo Nordisk Description and Business Overview
6.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio
6.2.5 Novo Nordisk Recent Developments/Updates
6.3 Synergy Pharmaceuticals (Salix)
6.3.1 Synergy Pharmaceuticals (Salix) Company Information
6.3.2 Synergy Pharmaceuticals (Salix) Description and Business Overview
6.3.3 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Product Portfolio
6.3.5 Synergy Pharmaceuticals (Salix) Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Oral Proteins and Peptides Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Novartis Oral Proteins and Peptides Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Chiasma (Amryt Pharma)
6.5.1 Chiasma (Amryt Pharma) Company Information
6.5.2 Chiasma (Amryt Pharma) Description and Business Overview
6.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio
6.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Proteins and Peptides Industry Chain Analysis
7.2 Oral Proteins and Peptides Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Proteins and Peptides Production Mode & Process Analysis
7.4 Oral Proteins and Peptides Sales and Marketing
7.4.1 Oral Proteins and Peptides Sales Channels
7.4.2 Oral Proteins and Peptides Distributors
7.5 Oral Proteins and Peptides Customer Analysis
8 Oral Proteins and Peptides Market Dynamics
8.1 Oral Proteins and Peptides Industry Trends
8.2 Oral Proteins and Peptides Market Drivers
8.3 Oral Proteins and Peptides Market Challenges
8.4 Oral Proteins and Peptides Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Proteins and Peptides Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Oral Proteins and Peptides Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Oral Proteins and Peptides Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Oral Proteins and Peptides Sales (Kg) of Key Manufacturers (2021–2026)
 Table 5. Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Oral Proteins and Peptides Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Oral Proteins and Peptides Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Oral Proteins and Peptides Average Price (US$/kg) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Oral Proteins and Peptides, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Oral Proteins and Peptides, Product Types and Applications
 Table 12. Global Key Manufacturers of Oral Proteins and Peptides, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Proteins and Peptides Companies by Tier (Tier 1, Tier 2, Tier 3), based on Oral Proteins and Peptides Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Oral Proteins and Peptides Sales by Region (Kg), 2021–2026
 Table 18. Global Oral Proteins and Peptides Sales Market Share by Region (2021–2026)
 Table 19. Global Oral Proteins and Peptides Sales by Region (Kg), 2027–2032
 Table 20. Global Oral Proteins and Peptides Sales Market Share by Region (2027–2032)
 Table 21. Global Oral Proteins and Peptides Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Oral Proteins and Peptides Revenue Market Share by Region (2021–2026)
 Table 23. Global Oral Proteins and Peptides Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Oral Proteins and Peptides Revenue Market Share by Region (2027–2032)
 Table 25. North America Oral Proteins and Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Oral Proteins and Peptides Sales by Country (Kg), 2021–2026
 Table 27. North America Oral Proteins and Peptides Sales by Country (Kg), 2027–2032
 Table 28. North America Oral Proteins and Peptides Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Oral Proteins and Peptides Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Oral Proteins and Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Oral Proteins and Peptides Sales by Country (Kg), 2021–2026
 Table 32. Europe Oral Proteins and Peptides Sales by Country (Kg), 2027–2032
 Table 33. Europe Oral Proteins and Peptides Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Oral Proteins and Peptides Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Oral Proteins and Peptides Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Oral Proteins and Peptides Sales by Region (Kg), 2021–2026
 Table 37. Asia Pacific Oral Proteins and Peptides Sales by Region (Kg), 2027–2032
 Table 38. Asia Pacific Oral Proteins and Peptides Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Oral Proteins and Peptides Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Oral Proteins and Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Oral Proteins and Peptides Sales by Country (Kg), 2021–2026
 Table 42. Latin America Oral Proteins and Peptides Sales by Country (Kg), 2027–2032
 Table 43. Latin America Oral Proteins and Peptides Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Oral Proteins and Peptides Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Oral Proteins and Peptides Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Oral Proteins and Peptides Sales by Country (Kg), 2021–2026
 Table 47. Middle East and Africa Oral Proteins and Peptides Sales by Country (Kg), 2027–2032
 Table 48. Middle East and Africa Oral Proteins and Peptides Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Oral Proteins and Peptides Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Oral Proteins and Peptides Sales (Kg) by Type (2021–2026)
 Table 51. Global Oral Proteins and Peptides Sales (Kg) by Type (2027–2032)
 Table 52. Global Oral Proteins and Peptides Sales Market Share by Type (2021–2026)
 Table 53. Global Oral Proteins and Peptides Sales Market Share by Type (2027–2032)
 Table 54. Global Oral Proteins and Peptides Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Oral Proteins and Peptides Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Oral Proteins and Peptides Revenue Market Share by Type (2021–2026)
 Table 57. Global Oral Proteins and Peptides Revenue Market Share by Type (2027–2032)
 Table 58. Global Oral Proteins and Peptides Price (US$/kg) by Type (2021–2026)
 Table 59. Global Oral Proteins and Peptides Price (US$/kg) by Type (2027–2032)
 Table 60. Global Oral Proteins and Peptides Sales (Kg) by Application (2021–2026)
 Table 61. Global Oral Proteins and Peptides Sales (Kg) by Application (2027–2032)
 Table 62. Global Oral Proteins and Peptides Sales Market Share by Application (2021–2026)
 Table 63. Global Oral Proteins and Peptides Sales Market Share by Application (2027–2032)
 Table 64. Global Oral Proteins and Peptides Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Oral Proteins and Peptides Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Oral Proteins and Peptides Revenue Market Share by Application (2021–2026)
 Table 67. Global Oral Proteins and Peptides Revenue Market Share by Application (2027–2032)
 Table 68. Global Oral Proteins and Peptides Price (US$/kg) by Application (2021–2026)
 Table 69. Global Oral Proteins and Peptides Price (US$/kg) by Application (2027–2032)
 Table 70. Ironwood & Allergan (AbbVie) Company Information
 Table 71. Ironwood & Allergan (AbbVie) Description and Business Overview
 Table 72. Ironwood & Allergan (AbbVie) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 73. Ironwood & Allergan (AbbVie) Oral Proteins and Peptides Product
 Table 74. Ironwood & Allergan (AbbVie) Recent Developments/Updates
 Table 75. Novo Nordisk Company Information
 Table 76. Novo Nordisk Description and Business Overview
 Table 77. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 78. Novo Nordisk Oral Proteins and Peptides Product
 Table 79. Novo Nordisk Recent Developments/Updates
 Table 80. Synergy Pharmaceuticals (Salix) Company Information
 Table 81. Synergy Pharmaceuticals (Salix) Description and Business Overview
 Table 82. Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 83. Synergy Pharmaceuticals (Salix) Oral Proteins and Peptides Product
 Table 84. Synergy Pharmaceuticals (Salix) Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 88. Novartis Oral Proteins and Peptides Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Chiasma (Amryt Pharma) Company Information
 Table 91. Chiasma (Amryt Pharma) Description and Business Overview
 Table 92. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/kg), and Gross Margin (2021–2026)
 Table 93. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product
 Table 94. Chiasma (Amryt Pharma) Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Oral Proteins and Peptides Distributors List
 Table 98. Oral Proteins and Peptides Customers List
 Table 99. Oral Proteins and Peptides Market Trends
 Table 100. Oral Proteins and Peptides Market Drivers
 Table 101. Oral Proteins and Peptides Market Challenges
 Table 102. Oral Proteins and Peptides Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Proteins and Peptides
 Figure 2. Global Oral Proteins and Peptides Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Oral Proteins and Peptides Market Share by Type: 2025 & 2032
 Figure 4. Linaclotide Product Picture
 Figure 5. Insulin Product Picture
 Figure 6. Plecanatide Product Picture
 Figure 7. Cyclosporine Product Picture
 Figure 8. Octreotide Product Picture
 Figure 9. Global Oral Proteins and Peptides Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global Oral Proteins and Peptides Market Share by Application: 2025 & 2032
 Figure 11. Gastric & Digestive Disorders
 Figure 12. Bone Diseases
 Figure 13. Diabetes
 Figure 14. Hormonal Disorders
 Figure 15. Global Oral Proteins and Peptides Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 16. Global Oral Proteins and Peptides Market Size (US$ Million), 2021–2032
 Figure 17. Global Oral Proteins and Peptides Sales (Kg), 2021–2032
 Figure 18. Global Oral Proteins and Peptides Average Price (US$/kg), 2021–2032
 Figure 19. Oral Proteins and Peptides Report Years Considered
 Figure 20. Oral Proteins and Peptides Sales Share by Manufacturers in 2025
 Figure 21. Global Oral Proteins and Peptides Revenue Share by Manufacturers in 2025
 Figure 22. Top 5 and Top 10 Global Oral Proteins and Peptides Players: Market Share by Revenue in Oral Proteins and Peptides in 2025
 Figure 23. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 24. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 25. North America Oral Proteins and Peptides Sales Market Share by Country (2021–2032)
 Figure 26. North America Oral Proteins and Peptides Revenue Market Share by Country (2021–2032)
 Figure 27. United States Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Canada Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. Europe Oral Proteins and Peptides Sales Market Share by Country (2021–2032)
 Figure 30. Europe Oral Proteins and Peptides Revenue Market Share by Country (2021–2032)
 Figure 31. Germany Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. France Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. U.K. Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Italy Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Russia Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2021–2032)
 Figure 37. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2021–2032)
 Figure 38. China Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Japan Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. South Korea Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. India Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Australia Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. China Taiwan Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Indonesia Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Thailand Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Malaysia Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Oral Proteins and Peptides Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. UAE Oral Proteins and Peptides Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Oral Proteins and Peptides by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Oral Proteins and Peptides by Type (2021–2032)
 Figure 59. Global Oral Proteins and Peptides Price (US$/kg) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Oral Proteins and Peptides by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Oral Proteins and Peptides by Application (2021–2032)
 Figure 62. Global Oral Proteins and Peptides Price (US$/kg) by Application (2021–2032)
 Figure 63. Oral Proteins and Peptides Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS